Search
Neuphoria Therapeutics Inc
NEUPAdd to Watchlist
3.680USD
-0.055-1.47%
Close 09-23 16:00（ET）
19.87MMarket Cap
LossP/E TTM
NEUP Financials
See Neuphoria Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
19.87M
Dividend TTM
0.00
P/E TTM
-0.47
EPS TTM
-7.90
Revenue
1.17M
Net Profit
-369.63K
ROE
-62.90%
ROA
-53.21%
Neuphoria Therapeutics Inc Earnings Date
Latest Release
May 15, 2026
EPS / Forecast
--/-0.97
Revenue / Forecast
--/0.00
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
Revenue
By Business
Period:
No Data
By Region
Period:No Data
FAQs
What is the total revenue of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2026 earnings report, its total revenue reached 1.17M, with a year-on-year change of 15.65M.
What are the current assets of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2026 earnings report, its current assets were 21.07M, with a year-on-year change of 40.08.
What are the total assets of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2026 earnings report, its total assets of Neuphoria Therapeutics Inc were 28.71M, with a year-on-year change of 0.42.
What are the total liabilities of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2026 earnings report, its total liabilities of Neuphoria Therapeutics Inc were 4.11M, with a year-on-year change of -57.14.
What is the total equity of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2026 earnings report, its total equity of Neuphoria Therapeutics Inc was 24.60M, with a year-on-year change of 29.46.
What is the net operating income of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2026 earnings report, its net operating income of Neuphoria Therapeutics Inc was -9.01M, with a year-on-year change of -986.56.
What is the net financing of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2026 earnings report, its net financing of Neuphoria Therapeutics Inc was 17.92M, with a year-on-year change of 1072.29.
What is the Earnings Per Share (EPS) of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2026 earnings report, its Earnings Per Share (EPS) was -3.06, with a year-on-year change of -1243.60.
What is the net income of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2026 earnings report, its net income was -13.45M, with a year-on-year change of -3539.28.
What is the net margin of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2026 earnings report, its net profit margin was -1145.66, with a year-on-year change of -48404.81.
What is the debt-to-asset ratio of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2026 earnings report, its debt-to-asset ratio was 0.12, with a year-on-year change of 4.43.
What is the Return on Equity (ROE) of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2026 earnings report, its Return on Equity (ROE) was -61.70, with a year-on-year change of -2945.87.
What is the Return on Assets (ROA) of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2026 earnings report, its Return on Assets (ROA) was -46.95, with a year-on-year change of -3471.96.
What is the operating profit of Neuphoria Therapeutics Inc?
According to Neuphoria Therapeutics Inc's FY2026 earnings report, its operating profit was -9.01M, with a year-on-year change of -986.56.